Amundi Xencor Inc Transaction History
Amundi
- $264 Billion
- Q3 2024
A detailed history of Amundi transactions in Xencor Inc stock. As of the latest transaction made, Amundi holds 10,886 shares of XNCR stock, worth $190,722. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,886
Previous 9,098
19.65%
Holding current value
$190,722
Previous $172,000
26.74%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XNCR
# of Institutions
215Shares Held
71.9MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$195 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$160 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$133 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$93.4 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$68.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.05B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...